Search Within

Neeta Pandit-Taskar

  1. "GSK Faculty"
Formats
  1. Meeting Abstract (74)
  2. Journal Article (69)
  3. Book Section (2)
Groups
  1. GSK Faculty (145)
  2. Molecular Imaging and Therapy Service (145)
  3. Radiology, Department of (145)
  4. Molecular Pharmacology and Chemistry Program Faculty (103)
  5. Sloan Kettering Institute Faculty (103)
  6. Medical Physics (83)

More Groups

People
  1. Steven Larson (99)
  2. Jorge Carrasquillo (61)
  3. Jason Lewis (52)
  4. Nai-Kong Cheung (48)
  5. Serge Lyashchenko (48)
  6. Pat Zanzonico (46)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (5)
  4. 2022 (10)
  5. 2021 (6)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (34)
  2. Journal of Nuclear Medicine (28)
  3. Neuro-Oncology (13)
  4. Pediatric Blood and Cancer (13)
  5. Clinical Cancer Research (11)
  6. European Journal of Nuclear Medicine and Molecular Imaging (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (34)
  2. Society of Nuclear Medicine (28)
  3. Springer (20)
  4. American Association for Cancer Research (15)
  5. Oxford University Press (14)
  6. Wiley Periodicals, Inc (13)

More Publishers

Results (145)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • STARLITE 2: Phase 2 study of nivolumab plus (177)lutetium-labeled anti-carbonic anhydrase IX (CAIX) monoclonal antibody girentuximab ((177)Lu-girentuximab) in patients with advanced clear cell renal cell carcinoma (ccRCC)
    Meeting Abstract

    Feldman, D. R.; Motzer, R. J.; Knezevic, A.; Voss, M. H.; Lyashchenko, S. K.; Park, H.; Larson, S. M.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Noninvasive assessment of programmed-death ligand-1 (PD-L1) in esophagogastric (EG) cancer using (18)F-BMS-986229 PET
    Meeting Abstract

    Cytryn, S. L.; Pandit-Taskar, N.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Feder, L.; Philemond, S.; Lyashchenko, S. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • MRI compared to (123)I-MIBG scan for detection of central nervous system relapse in neuroblastoma
    Meeting Abstract

    Stiefel, J.; Kramer, K.; Haque, S.; Basu, E. M.; Kushner, B. H.; Pandit-Taskar, N.; Katz, A.; Cheung, N. K. V.; Modak, S.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Off-label use of fam-trastuzumab deruxtecan-nxki with early activity in a cohort of patients with desmoplastic small round cell tumor
    Meeting Abstract

    Slotkin, E. K.; Burke, C.; Hameed, M.; Antonescu, C. R.; Agaram, N. P.; Bhanot, U.; Behr, G.; Price, A.; Pandit-Taskar, N.; Domenico, D.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • (18)F-BMS-986229 PET to assess programmed-death ligand 1 status in gastroesophageal cancer
    Journal Article

    Cytryn, S. L.; Pandit-Taskar, N.; Lumish, M. A.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Antoine, A.; Loegel, D.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Determinants of survival with combined HER2 and PD-1 blockade in metastatic esophagogastric cancer
    Journal Article

    Maron, S. B.; Chatila, W.; Walch, H.; Chou, J. F.; Ceglia, N.; Ptashkin, R.; Do, R. K. G.; Paroder, V.; Pandit-Taskar, N.; Lewis, J. S.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Noninvasive assessment of human epidermal growth factor receptor 2 (HER2) in esophagogastric cancer using (89)Zr-trastuzumab PET: A pilot study
    Journal Article

    Lumish, M. A.; Maron, S. B.; Paroder, V.; Chou, J. F.; Capanu, M.; Philemond, S.; O'Donoghue, J. A.; Schoder, H.; Lewis, J. S.; Lyashchenko, S. K.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma
    Journal Article

    Tringale, K. R.; Wolden, S. L.; Karajannis, M.; Haque, S.; Pasquini, L.; Yildirim, O.; Rosenblum, M.; Benhamida, J. K.; Cheung, N. K.; Souweidane, M.; more...
    Journal of Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • STARLITE 2: Phase 2 study of nivolumab plus (177)lutetium-labeled anti–carbonic anhydrase IX (CAIX) monoclonal antibody girentuximab ((177)Lu-girentuximab) in patients (pts) with advanced clear cell renal cell carcinoma (ccRCC)
    Meeting Abstract

    Feldman, D. R.; Motzer, R. J.; Knezevic, A.; Lee, C. H.; Voss, M. H.; Lyashchenko, S. K.; Park, H.; Larson, S. M.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical outcomes of pediatric patients receiving multimodality treatment of second central nervous system relapse of neuroblastoma
    Journal Article

    Tringale, K. R.; Wolden, S. L.; Casey, D. L.; Kushner, B. H.; Luo, L.; Pandit-Taskar, N.; Souweidane, M.; Cheung, N. K. V.; Modak, S.; Basu, E. M.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save